EBR Systems Wins Major HCA Deal to Accelerate WiSE CRT Rollout in U.S.

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) has shared an update.

EBR Systems has secured a purchasing agreement with HCA Healthcare, one of the largest U.S. healthcare networks with 190 hospitals and about 2,500 ambulatory sites across 19 states. The deal marks a key commercial milestone in the rollout of EBR’s WiSE cardiac resynchronisation therapy system and reflects growing reimbursement support for the technology.

The agreement streamlines procurement and contracting pathways for the WiSE System across HCA hospitals, expanding on EBR’s existing presence at sites in Austin and Fort Worth, Texas. It enables EBR’s sales representatives to engage more directly with HCA physicians and administrators, supporting broader hospital access, more efficient adoption and potentially accelerating U.S. commercial momentum for its leadless cardiac pacing solution.

The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

EBR Systems, Inc. is a Silicon Valley-based medical device company focused on treating cardiac rhythm disease through wireless cardiac pacing technologies. Its patented Wireless Stimulation Endocardially (WiSE) system is the world’s only wireless, endocardial left-ventricular pacing solution in clinical use, initially targeting heart failure patients requiring cardiac resynchronisation therapy in the U.S. market. Future applications may extend to bradycardia and other non-cardiac indications.

Average Trading Volume: 503,466

Technical Sentiment Signal: Sell

Current Market Cap: A$2.7B

See more insights into EBR stock on TipRanks’ Stock Analysis page.